Panacea Biotec: Making The Vaccine Shift
The company divested its pharma portfolio in India to fund a new thrust in vaccines against pandemic outbreaks.
The company divested its pharma portfolio in India to fund a new thrust in vaccines against pandemic outbreaks.
Fortune India's The Next 500 companies create new records with cumulative topline and profits hitting decadal highs.